HAART + ABV showed no clear difference in mortality compared with HAART alone (moderate certainty).
HAART + liposomal anthracycline showed no clear difference in kaposi's sarcoma IRIS compared with HAART alone (moderate certainty).
HAART + ABV probably leads to lower progressive disease compared with HAART alone (moderate certainty).
HAART + ABV showed no clear difference in clinical response ‐ complete response compared with HAART alone (moderate certainty).
HAART + ABV probably leads to higher clinical response ‐ partial response compared with HAART alone (moderate certainty).
HAART + ABV probably leads to lower clinical response ‐ stable disease compared with HAART alone (moderate certainty).
HAART + ABV probably leads to higher clinical response ‐ overall response (complete and partial) compared with HAART alone (moderate certainty).
HAART + ABV showed no clear difference in adverse events compared with HAART alone (moderate certainty).
HAART + pegylated liposomal doxorubicin showed no clear difference in clinical response compared with HAART alone (moderate certainty).
HAART + liposomal anthracycline showed no clear difference in mortality compared with HAART alone (moderate certainty).
It is very uncertain whether chemotherapy + ART changes complete Response to Tx compared with chemotherapy Alone (very low certainty).
It is very uncertain whether chemotherapy + ART changes complete/Partial Response to Tx compared with chemotherapy Alone (very low certainty).
It is very uncertain whether chemotherapy + ART changes complete Among Known Outcome compared with chemotherapy Alone (very low certainty).
It is very uncertain whether chemotherapy + ART changes complete/Partial Among Known Outcome compared with chemotherapy Alone (very low certainty).
It is very uncertain whether chemotherapy + ART changes mortality compared with chemotherapy Alone (very low certainty).
The intervention may leads to higher objective response rate2 (low certainty).
It is very uncertain whether artesunate (12 mg/kg) plus praziquantel (40 mg/kg) changes parasitological failure at 1 month compared with praziquantel (40 mg/kg) alone (very low certainty).
Aripiprazole leads to higher requirement for anticholinergics number of participants requiring… compared with placebo (high certainty).
Any Psychosocial intervention plus pharm showed no clear difference in retention in treatment Objective compared with pharm standard (high certainty).